My work on gut bacteria’s DNA inversions in inflammation was mentioned in the news
Check out the links below
Apr 10, 2024
December 15, 2024
“Among the innumerable research papers on inflammatory bowel disease (IBD) in 2024, three stood out. Two clinical studies highlighted the maturing cycle of biologic agent treatment strategies in clinical practice, and a basic science study disentangled the interaction between the gut microbiota, bacteriophages and the host immune system.”
Katsidzira, L., Misselwitz, B. Biologic agents for IBD come of age as host–microbe interactions emerge. Nat Rev Gastroenterol Hepatol 22, 94–95 (2025).